|
Model Number M332611H |
Device Problem
Fluid/Blood Leak (1250)
|
Patient Problems
Hemorrhage/Bleeding (1888); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/18/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that during use of a custom tubing pack, it was reported that there was significant blood loss at the inlet of the oxygenator.It appeared in cec while the patient was clamped and cardioplegia was in progress. a second collar was installed to reduce the leak and wax. the device was used to complete the procedure.There was no patient impact associated with this event.
|
|
Manufacturer Narrative
|
Device evaluation: visual inspection showed evidence of 2 tie bands and bone wax on the qb-inlet port.The bone wax was removed and there was not enough tubing to connect it for testing.There appears to be evidence of blood residue through the length of the remaining tubing.The section of tubing was removed, and pressure integrity testing was performed at 3 l/pm with 23 psi, (1189 mmhg) of back pressure for 10 minutes.During the pressure integrity testing there were no leaks observed from the device including the qb-inlet port.Reason for return was visually confirmed by the evidence of blood through the section of tubing and bone wax.Correction b3 date of event: this field has been updated.Correction b5: there was no additional patient impact associated with this event.Medtronic received additional information that the procedure was a valve surgery.The customer stated that blood loss was estimated at approximately 300ml.A transfusion was not required because of the leak.The customer stated that finger leak closure and transparent clamp placement by the perfusionist were used as a reinforcement to limit the leak and complete the procedure.The customer stated that there was not any visible air in the system/tubing.The customer stated that the inlet port was not broken or damaged.There was no damage to the packaging (outer box, inner packaging, or sterile barrier).The customer stated that performance was not affected due to the leak.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Conclusion: the complaint can be confirmed related to leaking connection of the qb inlet from the oxygenator.Performed device history check, no anomalies detected related to the production process.The actual leak can¿t be confirmed anymore, but most probable causes are either a defect of the tubing, more specifically the diameter, or the sta-strap and/or the tubing were not connected in the correct way.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|